Origins and Structure BPC-157 (Body Protection Compound-157) BPC-157 is a synthetic 15-amino acid peptide derived from a larger protective protein found in human gastric juice
Notably, even as long as 24 hours after dose administration, the blood glucose levels were reduced in the DehydraTECH GLP-1 group by 5.01% relative to baseline while the blood glucose levels evidenced in the Rybelsus Control group were unchanged
Celecoxib-induced gastrointestinal, liver and brain lesions in rats, counteraction by BPC 157 or L-arginine, aggravation by L-NAME
Method of Administration : BPC 157 can be taken either systemically (e.g., injecting subcutaneously a few inches from the belly button) or locally (injecting directly at or near the site of injury)
Despite not being a primary aim of the study, by collecting participant characteristics we saw clinically significant improvements in physical health (weight and HbA1c), of similar magnitude to that seen in trials of GLP-1 receptor agonists in obesity [35] and T2D and overweight [36, 37]